KEITH A BAGGERLY to Neoplasm, Residual
This is a "connection" page, showing publications KEITH A BAGGERLY has written about Neoplasm, Residual.
Connection Strength
0.100
-
Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer. Clin Cancer Res. 2014 Jun 15; 20(12):3280-8.
Score: 0.079
-
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Clin Cancer Res. 2015 Jun 15; 21(12):2704-14.
Score: 0.021